0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Cognition-Enhancing Drugs Market Report & Forecast 2022-2028
Published Date: June 2022
|
Report Code: QYRE-Auto-30C10234
Home | Market Reports | Health | Pharmacy
Global and United States Cognition Enhancing Drugs Market Report Forecast 2022 2028

Global and United States Cognition-Enhancing Drugs Market Report & Forecast 2022-2028

Code: QYRE-Auto-30C10234
Report
June 2022
92 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Cognition-enhancing drugs are purported to improve mental functions such as cognition, memory, intelligence, motivation, attention and concentration.
Market Analysis and Insights: Global and United States Cognition-Enhancing Drugs Market
This report focuses on global and United States Cognition-Enhancing Drugs market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Cognition-Enhancing Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, by Type, Oral accounting for % of the Cognition-Enhancing Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While by Application, Hospital Pharmacies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Cognition-Enhancing Drugs market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Global Cognition-Enhancing Drugs Scope and Market Size
Cognition-Enhancing Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cognition-Enhancing Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Cognition-Enhancing Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Oral
Injection

Segment by Application

Hospital Pharmacies
Drug Stores
Retail Pharmacies

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

BY COMPANY

Accelerated Intelligence
Cognition Therapeutics
Cogstate
HVMN
Biogen Idec
1 Study Coverage
1.1 Cognition-Enhancing Drugs Product Introduction
1.2 Global Cognition-Enhancing Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Cognition-Enhancing Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Cognition-Enhancing Drugs Sales in Volume for the Year 2017-2028
1.3 United States Cognition-Enhancing Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Cognition-Enhancing Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Cognition-Enhancing Drugs Sales in Volume for the Year 2017-2028
1.4 Cognition-Enhancing Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Cognition-Enhancing Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Cognition-Enhancing Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Cognition-Enhancing Drugs Market Dynamics
1.5.1 Cognition-Enhancing Drugs Industry Trends
1.5.2 Cognition-Enhancing Drugs Market Drivers
1.5.3 Cognition-Enhancing Drugs Market Challenges
1.5.4 Cognition-Enhancing Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Cognition-Enhancing Drugs Market Segment by Type
2.1.1 Oral
2.1.2 Injection
2.2 Global Cognition-Enhancing Drugs Market Size by Type
2.2.1 Global Cognition-Enhancing Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Cognition-Enhancing Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Cognition-Enhancing Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Cognition-Enhancing Drugs Market Size by Type
2.3.1 United States Cognition-Enhancing Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Cognition-Enhancing Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Cognition-Enhancing Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Cognition-Enhancing Drugs Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Drug Stores
3.1.3 Retail Pharmacies
3.2 Global Cognition-Enhancing Drugs Market Size by Application
3.2.1 Global Cognition-Enhancing Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Cognition-Enhancing Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Cognition-Enhancing Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Cognition-Enhancing Drugs Market Size by Application
3.3.1 United States Cognition-Enhancing Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Cognition-Enhancing Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Cognition-Enhancing Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Cognition-Enhancing Drugs Competitor Landscape by Company
4.1 Global Cognition-Enhancing Drugs Market Size by Company
4.1.1 Top Global Cognition-Enhancing Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Cognition-Enhancing Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Cognition-Enhancing Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Cognition-Enhancing Drugs Price by Manufacturer (2017-2022)
4.2 Global Cognition-Enhancing Drugs Concentration Ratio (CR)
4.2.1 Cognition-Enhancing Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cognition-Enhancing Drugs in 2021
4.2.3 Global Cognition-Enhancing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Cognition-Enhancing Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Cognition-Enhancing Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Cognition-Enhancing Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Cognition-Enhancing Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Cognition-Enhancing Drugs Market Size by Company
4.5.1 Top Cognition-Enhancing Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Cognition-Enhancing Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Cognition-Enhancing Drugs Sales by Players (2020, 2021 & 2022)
5 Global Cognition-Enhancing Drugs Market Size by Region
5.1 Global Cognition-Enhancing Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Cognition-Enhancing Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Cognition-Enhancing Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Cognition-Enhancing Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Cognition-Enhancing Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Cognition-Enhancing Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Cognition-Enhancing Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Cognition-Enhancing Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Cognition-Enhancing Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Cognition-Enhancing Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Cognition-Enhancing Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Cognition-Enhancing Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Cognition-Enhancing Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Cognition-Enhancing Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Cognition-Enhancing Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Cognition-Enhancing Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Cognition-Enhancing Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Accelerated Intelligence
7.1.1 Accelerated Intelligence Corporation Information
7.1.2 Accelerated Intelligence Description and Business Overview
7.1.3 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Accelerated Intelligence Cognition-Enhancing Drugs Products Offered
7.1.5 Accelerated Intelligence Recent Development
7.2 Cognition Therapeutics
7.2.1 Cognition Therapeutics Corporation Information
7.2.2 Cognition Therapeutics Description and Business Overview
7.2.3 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Cognition Therapeutics Cognition-Enhancing Drugs Products Offered
7.2.5 Cognition Therapeutics Recent Development
7.3 Cogstate
7.3.1 Cogstate Corporation Information
7.3.2 Cogstate Description and Business Overview
7.3.3 Cogstate Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Cogstate Cognition-Enhancing Drugs Products Offered
7.3.5 Cogstate Recent Development
7.4 HVMN
7.4.1 HVMN Corporation Information
7.4.2 HVMN Description and Business Overview
7.4.3 HVMN Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 HVMN Cognition-Enhancing Drugs Products Offered
7.4.5 HVMN Recent Development
7.5 Biogen Idec
7.5.1 Biogen Idec Corporation Information
7.5.2 Biogen Idec Description and Business Overview
7.5.3 Biogen Idec Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Biogen Idec Cognition-Enhancing Drugs Products Offered
7.5.5 Biogen Idec Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Cognition-Enhancing Drugs Industry Chain Analysis
8.2 Cognition-Enhancing Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Cognition-Enhancing Drugs Distributors
8.3 Cognition-Enhancing Drugs Production Mode & Process
8.4 Cognition-Enhancing Drugs Sales and Marketing
8.4.1 Cognition-Enhancing Drugs Sales Channels
8.4.2 Cognition-Enhancing Drugs Distributors
8.5 Cognition-Enhancing Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Cognition-Enhancing Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Cognition-Enhancing Drugs Market Trends
    Table 3. Cognition-Enhancing Drugs Market Drivers
    Table 4. Cognition-Enhancing Drugs Market Challenges
    Table 5. Cognition-Enhancing Drugs Market Restraints
    Table 6. Global Cognition-Enhancing Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cognition-Enhancing Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cognition-Enhancing Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cognition-Enhancing Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cognition-Enhancing Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cognition-Enhancing Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Cognition-Enhancing Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Cognition-Enhancing Drugs Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Cognition-Enhancing Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Cognition-Enhancing Drugs Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Cognition-Enhancing Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Cognition-Enhancing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognition-Enhancing Drugs as of 2021)
    Table 18. Top Players of Cognition-Enhancing Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Cognition-Enhancing Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Cognition-Enhancing Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Cognition-Enhancing Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Cognition-Enhancing Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Cognition-Enhancing Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Cognition-Enhancing Drugs Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Cognition-Enhancing Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Cognition-Enhancing Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Cognition-Enhancing Drugs Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Cognition-Enhancing Drugs Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Cognition-Enhancing Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Cognition-Enhancing Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Cognition-Enhancing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Cognition-Enhancing Drugs Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Cognition-Enhancing Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Cognition-Enhancing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Cognition-Enhancing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Cognition-Enhancing Drugs Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Cognition-Enhancing Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Accelerated Intelligence Corporation Information
    Table 43. Accelerated Intelligence Description and Business Overview
    Table 44. Accelerated Intelligence Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Accelerated Intelligence Cognition-Enhancing Drugs Product
    Table 46. Accelerated Intelligence Recent Development
    Table 47. Cognition Therapeutics Corporation Information
    Table 48. Cognition Therapeutics Description and Business Overview
    Table 49. Cognition Therapeutics Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Cognition Therapeutics Product
    Table 51. Cognition Therapeutics Recent Development
    Table 52. Cogstate Corporation Information
    Table 53. Cogstate Description and Business Overview
    Table 54. Cogstate Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Cogstate Product
    Table 56. Cogstate Recent Development
    Table 57. HVMN Corporation Information
    Table 58. HVMN Description and Business Overview
    Table 59. HVMN Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. HVMN Product
    Table 61. HVMN Recent Development
    Table 62. Biogen Idec Corporation Information
    Table 63. Biogen Idec Description and Business Overview
    Table 64. Biogen Idec Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Biogen Idec Product
    Table 66. Biogen Idec Recent Development
    Table 67. Key Raw Materials Lists
    Table 68. Raw Materials Key Suppliers Lists
    Table 69. Cognition-Enhancing Drugs Customers List
    Table 70. Cognition-Enhancing Drugs Distributors List
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cognition-Enhancing Drugs Product Picture
    Figure 2. Global Cognition-Enhancing Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cognition-Enhancing Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Cognition-Enhancing Drugs Sales 2017-2028 (K MT)
    Figure 5. United States Cognition-Enhancing Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Cognition-Enhancing Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Cognition-Enhancing Drugs Sales 2017-2028 (K MT)
    Figure 8. United States Cognition-Enhancing Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Cognition-Enhancing Drugs Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Cognition-Enhancing Drugs Report Years Considered
    Figure 11. Product Picture of Oral
    Figure 12. Product Picture of Injection
    Figure 13. Global Cognition-Enhancing Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global Cognition-Enhancing Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Cognition-Enhancing Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Cognition-Enhancing Drugs Sales by Type (2017-2028) & (K MT)
    Figure 17. Global Cognition-Enhancing Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Cognition-Enhancing Drugs Price by Type (2017-2028) & (USD/MT)
    Figure 19. United States Cognition-Enhancing Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States Cognition-Enhancing Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Cognition-Enhancing Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Cognition-Enhancing Drugs Sales by Type (2017-2028) & (K MT)
    Figure 23. United States Cognition-Enhancing Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Cognition-Enhancing Drugs Price by Type (2017-2028) & (USD/MT)
    Figure 25. Product Picture of Hospital Pharmacies
    Figure 26. Product Picture of Drug Stores
    Figure 27. Product Picture of Retail Pharmacies
    Figure 28. Global Cognition-Enhancing Drugs Market Share by Application in 2022 & 2028
    Figure 29. Global Cognition-Enhancing Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Cognition-Enhancing Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Cognition-Enhancing Drugs Sales by Application (2017-2028) & (K MT)
    Figure 32. Global Cognition-Enhancing Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Cognition-Enhancing Drugs Price by Application (2017-2028) & (USD/MT)
    Figure 34. United States Cognition-Enhancing Drugs Market Share by Application in 2022 & 2028
    Figure 35. United States Cognition-Enhancing Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Cognition-Enhancing Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Cognition-Enhancing Drugs Sales by Application (2017-2028) & (K MT)
    Figure 38. United States Cognition-Enhancing Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Cognition-Enhancing Drugs Price by Application (2017-2028) & (USD/MT)
    Figure 40. North America Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 41. North America Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 45. Europe Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 52. Asia-Pacific Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 64. Latin America Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Cognition-Enhancing Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 69. Middle East & Africa Cognition-Enhancing Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Cognition-Enhancing Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Cognition-Enhancing Drugs Value Chain
    Figure 74. Cognition-Enhancing Drugs Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4350
This license allows only one user to access the PDF.

Electronic (PDF)
$6525
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8700
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global and United States Low dosage Hydrate Inhibitors Market Report Forecast 2022 2028
Global and United States Low dosage Hydrate Inhibitors Market Report & Forecast 2022-2028

Low dosage hydrate inhibitors are chemicals that help manage flow without the huge volume of chemicals that are required for thermodynamic inhibition.Market Analysis and Insights Global and United States Low dosage Hydrate Inhibitors MarketThis report focuses on global and United States Low dosage Hydrate Inhibitors market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Low dosage Hydrate Inhibitors market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-8W10686
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Cognition Enhancing Drugs Market Report Forecast 2022 2028
Global and United States Cognition-Enhancing Drugs Market Report & Forecast 2022-2028

Cognitionenhancing drugs are purported to improve mental functions such as cognition memory intelligence motivation attention and concentration.Market Analysis and Insights Global and United States CognitionEnhancing Drugs MarketThis report focuses on global and United States CognitionEnhancing Drugs market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global CognitionEnhancing Drugs market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-30C10234
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Nanopharmaceutical Drugs Market Report Forecast 2022 2028
Global and United States Nanopharmaceutical Drugs Market Report & Forecast 2022-2028

The increasing prevalence of chronic diseases and development of the healthcare infrastructure are promoting the adoption of the novel medicine known as nanomedicine for better efficacy and improved patient outcome.Market Analysis and Insights Global and United States Nanopharmaceutical Drugs MarketThis report focuses on global and United States Nanopharmaceutical Drugs market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Nanopharmaceutical Drugs market size is estimated to be worth US 35330 million in 2022 and is forecast to a readjusted size of US 72540 million by 2028 with a CAGR of 12.7 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24J10248
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Neuroprotective Agents Market Report Forecast 2022 2028
Global and United States Neuroprotective Agents Market Report & Forecast 2022-2028

Neuroprotective agents are medications that can alter the course of metabolic events after the onset of ischemia and therefore have the potential to reduce stroke damage.Market Analysis and Insights Global and United States Neuroprotective Agents MarketThis report focuses on global and United States Neuroprotective Agents market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Neuroprotective Agents market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-12W10567
Tue Jun 07 00:00:00 UTC 2022

Add to Cart